NARA Discovery
Article Details
← Back to Search Results
Journal Article

Rapidly Dissolving Trans-scleral Microneedles for Intraocular Delivery of Cyclosporine A

Hamad Alrbyawi; Manjusha Annaji; Oladiran Fasina; Srinath Palakurthi; Sai H. S. Boddu; Nageeb Hassan; Amit K. Tiwari; Amol Suryawanshi; R. Jayachandra Babu
AAPS PharmSciTech · Vol. 25, Issue 2 · 2024

Abstract

Cyclosporine A (CsA) is a cyclic peptide immunosuppressant drug that is beneficial in the treatment of various ocular diseases. However, its ocular bioavailability in the posterior eye is limited due to its poor aqueous solubility. Conventional CsA formulations such as a solution or emulsion permeate poorly across the eye due to various static and dynamic barriers of the eye. Dissolvable microneedle (MN)-based patches can be used to overcome barrier properties and, thus, enhance the ocular bioavailability of CsA in the posterior eye. CsA-loaded dissolvable MN patches were fabricated using polyvinylpyrrolidone (PVP) and characterized for MN uniformity and sharpness using SEM. Further characterization for its failure force, penetration force, and depth of penetration were analyzed using a texture analyzer. Finally, the dissolution time, ex vivo permeation, and ocular distribution of cyclosporine were determined in isolated porcine eyes. PVP MNs were sharp, uniform with good mechanical properties, and dissolved within 5 min. Ocular distribution of CsA in a whole porcine eye perfusion model showed a significant increase of CsA levels in various posterior segment ocular tissues as compared to a topically applied ophthalmic emulsion (Restasis®) ( P

Bibliographic Information

JournalAAPS PharmSciTech
PublisherSpringer
Publication Date2024-02-01
Publication Year2024
Volume25
Issue2
Document TypeJournal Article
eISSN1530-9932
DOI10.1208/s12249-024-02738-5

Access Information

NARA Access Coverage2000-01-01~Current
Journal Homepagehttps://www.springer.com/journal/12249
Publisher PageOpen Publisher Page
Full-text access depends on NARA's subscribed coverage and institutional access.